Authors/Disclosures
|
Bakri Elsheikh, MD, FAAN
(The Ohio State University Wexner Medical Center)
|
Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA. |
|
Fahad F. Albassam, MD
(King Fahd Medical City)
|
No disclosure on file |
|
|
No disclosure on file |
|
Francesca Gilli
(Ospedale San Luigi)
|
No disclosure on file |
|
|
No disclosure on file |
|
Robert G. Miller, MD
(Dept Of Neurology, CA Pacific)
|
The institution of Dr. Miller has received research support from Nurown. |
|
Stephen J. Kolb, MD, PhD
(The Ohio State University)
|
Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH. |
|
Dan Moore, PhD
(California Pacific Medical Center)
|
No disclosure on file |
|
Walter G. Bradley, DM, FRCP, FAAN
|
No disclosure on file |
|
Richard J. Barohn, MD, FAAN
(University of Missouri)
|
Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care. |
|
Wilson W. Bryan, MD
|
Dr. Bryan has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Office of Tissues and Advanced Therapies with United States Food and Drug Administration (FDA). |
|
Deborah Gelinas, MD
(ARGENX)
|
Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx. |
|
|
No disclosure on file |
|
Robert T. Leshner, MD, FAAN
(University of California San Diegp)
|
No disclosure on file |
|
Jerry R. Mendell, MD, FAAN
(The Research Institute at Nationwide Children's Hospital)
|
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |
|
|
No disclosure on file |
|
Barry S. Russman, MD
(OHSU)
|
No disclosure on file |
|
Stephen A. Smith, MD
(Gillette Children'S Specialty Healthcare)
|
No disclosure on file |
|
John T. Kissel, MD, FAAN
|
Dr. Kissel has nothing to disclose. |